Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...

The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.

A unique property of cancer cells is their ability to undergo metabolic reprogramming, during which they preferentially utilize aerobic glycolysis, glutaminolysis, mitochondrial respiration, and other ...

Wahnefried, Ph.D. and Benjamin Larimer, Ph.D. Researchers at the University of Alabama at Birmingham are advancing cancer ...

Nutrition is increasingly recognized as a modifiable factor influencing the risk, progression, and survivorship of cancers that disproportionately affect ...

The breast cancer journey presents unique challenges for Black women, who often face different treatment responses and side effect experiences. While medical interventions remain the foundation of ...

A new study coordinated by Dr. Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist at Temple University and the ...

Following surgical treatment of gastric cancer -- often a complete or partial gastrectomy -- long-term cancer care is ...

As Ben Franklin once famously said, “An ounce of prevention is worth a pound of cure,” and that adage applies to cancer. February is Cancer Prevention Month, which is the perfect time to reflect on ...